Form 4: Guardant Health Director Acquires Shares Through Stock Unit Vesting
SEC Form 4 Filing
Myrtle S. Potter, a director at Guardant Health, acquired 68 shares of common stock through the vesting of restricted stock units.
Summary
- Myrtle S. Potter, a director at Guardant Health, acquired 68 shares of common stock on November 15, 2024.
- The acquisition was a result of the vesting of restricted stock units.
- The price per share was $0 as the shares were acquired through vesting.
- Following the transaction, Ms. Potter directly owns 13,653 shares of Guardant Health common stock.
- The restricted stock units vest over a period of three years, with 25% vesting on October 15, 2022, and the remaining 75% vesting in monthly installments.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation. It is neither particularly positive nor negative, but indicates a normal course of business.
Positives
- The vesting of restricted stock units indicates a continued alignment of interests between the director and the company's long-term performance.
Industry Context
This is a routine filing related to insider transactions and is common for publicly traded companies. It reflects the standard practice of compensating directors with equity that vests over time.
Comparison to Industry Standards
- The vesting schedule of the restricted stock units, with 25% vesting initially and the remainder over three years, is a common practice in the technology and biotech industries.
- Many companies, such as Illumina and Exact Sciences, use similar equity-based compensation plans for their directors and executives.
- The reporting of these transactions via SEC Form 4 is a standard regulatory requirement for all publicly traded companies in the US.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns director interests with the company's long-term performance.
Key Dates
| Date | Description |
|---|---|
| 10/15/2022 | 25% of the restricted stock units vested on this date. |
| 11/15/2024 | Date of the transaction where 68 shares were acquired through vesting of restricted stock units. |
| 11/18/2024 | Date the Form 4 was signed. |
Keywords
Guardant Health, Director, Myrtle S. Potter, Stock Acquisition, Restricted Stock Units, Vesting, Form 4, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.